Every year we invest our expertise into researching an emergent trend, development, or unmet need in healthcare. We do this as a call to arms in the industry, to create a community of like-minded individuals to collaborate with us to drive better healthcare for patients, carers and healthcare professionals alike. Our award-winning thought leadership campaigns have been critically acclaimed by leading organisations including The Guardian, Financial Times, Harvard University and Manchester Business School to name a few.
Media Means Business
COVID-19 has left us more reliant on media than ever – both the pharma industry and society as a whole. Our new white paper provides a blueprint for pharma brands to inject meaning into their media.
Meaningful media experiences are made by connecting with the right people, in the contexts where they spend their time, with content that drives impact. If a campaign does this, it will position a brand as trusting, engaging and influential, and deliver measurable performance.
Like so many others, the job of the pharma sales rep has been dramatically affected by the outbreak of COVID-19. A role built on interpersonal relations had its foremost tool – face-to-face meetings – rendered impossible in an instant. Sales forces have been admirably quick to adapt, but the situation accentuates an issue that many in the industry will already be aware of. A sales force cannot do it all – a successful pharma brand needs a clear purpose, strategy, meaningful creative idea, and an effective media plan.